文献速递胃肠动力与功能性疾病

用简单微创的辣椒素口服试验识别功能性消化不良患者:单中心队列研究

Identification of Individuals with Functional Dyspepsia With a Simple, Minimally Invasive Test: A Single Center Cohort Study of the Oral Capsaicin Test.
PubMed 文献 · Am J Gastroenterol · 2018-03-13

该单中心队列研究纳入224例无警报症状、因胃肠道症状就诊的门诊患者,吞服含0.75 mg辣椒素的胶囊并用分级问卷评估症状变化。结果显示辣椒素试验对功能性消化不良(FD)诊断的敏感性为0.51-0.59、特异性为0.84-0.89、阳性预测值为70-71%,FD患者症状评分差值中位数显著高于炎症性肠病、消化性溃疡病、肠易激综合征及「其他疾病」患者。作者认为辣椒素超敏反应可区分FD与其他胃肠道疾病。

要点

  • 辣椒素试验诊断FD的敏感性0.51-0.59、特异性0.84-0.89、阳性预测值70-71%。
  • FD患者症状评分差值中位数10.0,显著高于炎症性肠病、消化性溃疡病、肠易激综合征及「其他疾病」患者。
  • 作者认为辣椒素试验是检测化学超敏FD亚组的简单、非侵入性方法。

核心结论

  • 辣椒素超敏反应可将功能性消化不良与其他胃肠道疾病患者区分开。
  • 辣椒素试验是检测伴化学超敏反应的功能性消化不良大亚组的简单、非侵入性方法。
  • 这些发现可能为功能性消化不良开辟新的诊断选择,并可能通过靶向特异性辣椒素受体TRPV1开辟新的治疗选择。

研究设计与样本

  • 单中心队列研究,共纳入224例因胃肠道症状转诊、无警报症状的门诊患者。
  • 患者吞服含0.75 mg辣椒素的胶囊,用分级问卷评估吞服前后症状严重程度并计算症状总评分差值(delta)。

主要发现

  • 试验敏感性为0.51-0.59,特异性为0.84-0.89,FD诊断阳性预测值为70-71%。
  • FD患者症状评分差值中位数为10.0(25%四分位数3.0;75%四分位数16.0)。
  • FD患者症状评分差值中位数高于炎症性肠病(2.5;1.0/8.5)(P=0.003)、消化性溃疡病(0.0;-1.5/4.5)(P<0.001)、肠易激综合征(3.0;0.5/8.5)(P=0.001)及「其他疾病」患者(2.5;0.0/5.0)(P<0.001)。
  • 未同时诊断FD的胃食管反流病患者症状评分(2.0;0.0/6.0)显著低于同时存在FD者(10.0;4.0/15.0)。

临床怎么用

  • 作者认为辣椒素试验是检测伴化学超敏反应的功能性消化不良大亚组的简单、非侵入性方法。
  • 作者认为这些发现可能为功能性消化不良开辟新的诊断选择,并可能通过靶向辣椒素受体TRPV1开辟新的治疗选择。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: The diagnosis of functional dyspepsia (FD) is challenging due to the lack of reliable biological markers to support the diagnosis. We assessed the relevance of a previously validated simple test for chemical hypersensitivity in the setting of a gastrointestinal outpatient department. METHODS: A total of 224 outpatients who were referred for evaluation of gastrointestinal symptoms in the absence of alarm symptoms swallowed a capsule containing 0.75 mg capsaicin. Severity of symptoms before and after capsule ingestion was assessed by a graded questionnaire and the difference in aggregate symptom scores (delta) was calculated. RESULTS: Sensitivity of the test was between 0.51-0.59, specificity was 0.84-0.89 and positive predictive value for the diagnosis of FD 70-71%. FD patients had significantly higher median delta symptom scores (10.0; 25% quartile: 3.0; 75% quartile: 16.0) as compared to inflammatory bowel disease (2.5; 1.0/8.5)(P=0.003), peptic ulcer disease (0.0; -1.5/4.5) (P<0.001), irritable bowel syndrome (3.0;0.5/8.5)(P=0.001), and patients classified with "other disease" (2.5;0.0/5.0)(P<0.001). Patients with gastroesophageal reflux disease had significantly lower symptom scores if FD was not concomitantly diagnosed (2.0; 0.0/6.0) than if FD was present (10.0; 4.0/15.0). CONCLUSIONS: Hypersensitivity for capsaicin discriminates functional dyspepsia from patients with other GI disorders. The capsaicin test is a simple and non invasive method to detect a large subgroup of functional dyspepsia with chemical hypersensitivity. These findings might open new diagnostic options in functional dyspepsia and possibly new therapeutic options by targeting the specific capsaicin receptor TRPV1.

来源:Am J Gastroenterol,查看原文。版权归原作者所有。

引用

  1. Hammer J. Identification of Individuals with Functional Dyspepsia With a Simple, Minimally Invasive Test: A Single Center Cohort Study of the Oral Capsaicin Test. Am J Gastroenterol. 2018. PMID: 29533398. doi:10.1038/ajg.2018.16

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。